Maximus (NYSE:MMS) Releases FY 2025 Earnings Guidance

Maximus (NYSE:MMS - Get Free Report) updated its FY 2025 earnings guidance on Thursday. The company provided EPS guidance of 5.900-6.200 for the period, compared to the consensus EPS estimate of 5.950. The company issued revenue guidance of $5.2 billion-$5.4 billion, compared to the consensus revenue estimate of $5.3 billion.

Maximus Trading Down 0.2 %

Shares of MMS traded down $0.14 during mid-day trading on Friday, reaching $69.86. 1,378,914 shares of the company's stock traded hands, compared to its average volume of 679,035. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.72 and a quick ratio of 1.49. The stock's 50-day moving average is $74.73 and its two-hundred day moving average is $83.32. Maximus has a 12 month low of $68.30 and a 12 month high of $93.97. The stock has a market cap of $3.99 billion, a P/E ratio of 15.02 and a beta of 0.72.

Maximus (NYSE:MMS - Get Free Report) last announced its quarterly earnings data on Thursday, February 6th. The health services provider reported $1.61 EPS for the quarter, beating the consensus estimate of $1.39 by $0.22. Maximus had a return on equity of 21.95% and a net margin of 5.28%. Research analysts forecast that Maximus will post 6.05 earnings per share for the current fiscal year.

Maximus Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 28th. Investors of record on Saturday, February 15th will be issued a dividend of $0.30 per share. The ex-dividend date of this dividend is Friday, February 14th. This represents a $1.20 dividend on an annualized basis and a yield of 1.72%. Maximus's payout ratio is 25.81%.

Analyst Ratings Changes

A number of brokerages have recently commented on MMS. StockNews.com raised shares of Maximus from a "hold" rating to a "buy" rating in a research report on Thursday. Raymond James raised Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 price objective on the stock in a research note on Thursday, January 2nd.

Insider Activity at Maximus

In related news, insider Michelle F. Link sold 2,208 shares of the business's stock in a transaction that occurred on Tuesday, December 3rd. The shares were sold at an average price of $73.83, for a total value of $163,016.64. Following the completion of the transaction, the insider now owns 6,567 shares of the company's stock, valued at $484,841.61. The trade was a 25.16 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Bruce Caswell bought 3,500 shares of the stock in a transaction on Tuesday, December 17th. The shares were bought at an average price of $70.64 per share, with a total value of $247,240.00. Following the acquisition, the chief executive officer now owns 275,929 shares of the company's stock, valued at $19,491,624.56. This trade represents a 1.28 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders bought 7,063 shares of company stock worth $502,017 over the last three months. 1.60% of the stock is owned by corporate insiders.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.